KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aurinia Pharmaceuticals (AUPH) Inventory Average (2020 - 2025)

Historic Inventory Average for Aurinia Pharmaceuticals (AUPH) over the last 5 years, with Q3 2025 value amounting to $45.6 million.

  • Aurinia Pharmaceuticals' Inventory Average rose 1769.95% to $45.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.6 million, marking a year-over-year increase of 1769.95%. This contributed to the annual value of $39.5 million for FY2024, which is 2245.84% up from last year.
  • Per Aurinia Pharmaceuticals' latest filing, its Inventory Average stood at $45.6 million for Q3 2025, which was up 1769.95% from $46.3 million recorded in Q2 2025.
  • Over the past 5 years, Aurinia Pharmaceuticals' Inventory Average peaked at $46.3 million during Q2 2025, and registered a low of $11.3 million during Q1 2021.
  • Its 5-year average for Inventory Average is $30.9 million, with a median of $32.4 million in 2023.
  • As far as peak fluctuations go, Aurinia Pharmaceuticals' Inventory Average soared by 10090.78% in 2022, and later skyrocketed by 746.91% in 2024.
  • Aurinia Pharmaceuticals' Inventory Average (Quarter) stood at $19.3 million in 2021, then grew by 29.66% to $25.0 million in 2022, then surged by 44.84% to $36.3 million in 2023, then increased by 7.47% to $39.0 million in 2024, then increased by 17.13% to $45.6 million in 2025.
  • Its Inventory Average stands at $45.6 million for Q3 2025, versus $46.3 million for Q2 2025 and $42.7 million for Q1 2025.